Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,824 | 200 | 5,304 | 64 | 5,802 |
| Receivables | 3,567 | 1,140 | 1,042 | N/A | N/A |
| TOTAL | $70,176 | $1,505 | $6,913 | $2,448 | $6,196 |
| Non-Current Assets | |||||
| PPE Net | 3 | 6 | 7 | 23 | 35 |
| Intangibles | 130 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 357 | 867 | 0 | 0 | 0 |
| TOTAL | $490 | $873 | $7 | $23 | $35 |
| Total Assets | $70,656 | $2,378 | $6,920 | $2,471 | $6,231 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 324 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 7,306 | 6,990 | 6,401 | 4,749 | 2,143 |
| Other current liabilities | 85 | 82 | N/A | N/A | N/A |
| TOTAL | $7,980 | $7,351 | $6,401 | $4,749 | $2,143 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 290 | 541 | 0 | 0 | 0 |
| TOTAL | $290 | $541 | $N/A | $N/A | $N/A |
| Total Liabilities | $8,270 | $7,892 | $6,401 | $4,749 | $2,143 |
| Shareholders' Equity | |||||
| Common Shares | 97 | 8,599 | 8,592 | 8,141 | 6,903 |
| Retained earnings | -84,646 | -60,044 | -50,721 | -42,613 | -29,726 |
| Other shareholders' equity | 146,935 | 6,000 | 2,816 | 910 | 17,968 |
| TOTAL | $62,386 | $-5,514 | $519 | $-2,278 | $4,088 |
| Total Liabilities And Equity | $70,656 | $2,378 | $6,920 | $2,471 | $6,231 |